StockData

Zhengye Biotechnology Holding Ltd (ZYBT) stock

ZYBTNasdaqPharmaceutical Preparations
Financials through fiscal 2025, year ended Dec 31, 2025Last filing: 20-F on Apr 28, 2026Score 4/30
$1.50−0.02 (-1.32%)

Close on Nov 18, 2026Market cap $71.09MP/E –Yield –

Zhengye Biotechnology price to book ratio

The price-to-book ratio is market cap divided by shareholders' equity.

Zhengye Biotechnology's price to book ratio was 1.9× on Nov 11, 2026, against 2.3× a year earlier.

Price to Book Ratio at the end of each year

PeriodPeriod endValueChange (pts)
2026Nov 11, 20261.9×+0.7
2025Dec 31, 20251.2×–

More Zhengye Biotechnology figures

See a number that looks wrong?